Fertility preservation for cancer patients (oncofertility) is still a relatively new discipline, given the increase in survival rates of patients undergoing chemotherapy. Ovarian stimulation followed by cryopreservation are the routine techniques recommended for post-pubertal cancer patients (The ESHRE Guideline Group on Female Fertility Preservation et al., 2020). However, there are many patients who have a contraindication for ovarian stimulation, need an urgent anticancer treatment or are pre-pubertal. Despite the impressive progress in fertility preservation in recent decades, we still lack options with proven safety and efficacy for many of these patients.

中文翻译：

---

#ESHREjc 报告：OTO-IVM 是未来紧急癌症患者保留生育能力的替代方案吗？

考虑到接受化疗的患者存活率的提高，癌症患者的生育力保留（oncofertility）仍然是一个相对较新的学科。卵巢刺激后冷冻保存是推荐用于青春期后癌症患者的常规技术（ESHRE 女性生育力保存指南组等人，2020 年）。然而，有许多患者存在卵巢刺激禁忌症、需要紧急抗癌治疗或处于青春期前。尽管近几十年来在保留生育能力方面取得了令人瞩目的进展，但我们仍然缺乏对这些患者中的许多患者具有经证实的安全性和有效性的选择。